Drug intelligence / Profile preview

methylcobalamin + alpha lipoic acid + pyridoxine + folic acid

Development stage
Unknown
Lead developer
Jenburkt Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Nervijen is a multi-ingredient pharmaceutical product developed and marketed by Jenburkt Pharmaceuticals, primarily indicated for the management of peripheral neuropathy, including diabetic neuropathy. The formulation typically consists of **methylcobalamin** (an active form of Vitamin B12), **alpha lipoic acid** (thioctic acid), **pyridoxine** (Vitamin B6), and **folic acid**. Methylcobalamin acts as a cofactor for methionine synthase, which is essential for the synthesis of myelin and the regeneration of damaged neurons. Alpha lipoic acid serves as a potent antioxidant and a mitochondrial cofactor that helps reduce oxidative stress and improve nerve conduction velocity. Pyridoxine and folic acid support essential metabolic pathways and DNA repair mechanisms necessary for maintaining neuronal health. While primarily available as an oral capsule, the Nervijen brand also includes injectable formulations and variants with additional ingredients like benfotiamine.

Brand names
Nervijen
Other names
Nervijen Capsule
02

Targets

DDC (Aromatic L-amino acid decarboxylase)DHFR (Dihydrofolate reductase)MTR (Methionine synthase)PDH (Pyruvate dehydrogenase complex)

Beyond the preview

Go deeper on methylcobalamin + alpha lipoic acid + pyridoxine + folic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylcobalamin + alpha lipoic acid + pyridoxine + folic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call